Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
In the case of most cancers, generally the best questions go unasked. Listed here are 10 widespread—and essential—questions individuals typically take into consideration.
1....
Newswise — Little is understood concerning the genetics and biology of chordoma, a uncommon and aggressive bone tumor. Chordomas happen in roughly one...
In a dialog with CancerNetwork® on the 2024 European Hematology Affiliation (EHA) Congress, Eunice S. Wang, MD, highlighted findings associated to the usage...
